Comparison of Oral Octreotide Capsules to Injectable Somatostatin Analogs in Acromegaly
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Acromegaly
Related studies linked through entity extraction aliases.
Pasireotide LAR and Pegvisomant Study in Acromegaly
- Status
- UNKNOWN
- Phase
- PHASE4
Validation Study of the SAGIT® Instrument in Acromegaly
- Status
- COMPLETED
- Phase
- N/A
Efficacy and Safety of Lanreotide Autogel® 60, 90 or 120 mg With Lanreotide 40 mg Prolonged Release (PR) in Acromegaly
- Status
- COMPLETED
- Phase
- PHASE3
Hormonal Outcomes in Acromegalic Patients With Treated Surgery With or Without Long Acting Somatostatin Analogues
- Status
- UNKNOWN
- Phase
- PHASE4
Assessment of Airway in Patients With Acromegaly for Predicting Successful Tracheal Intubation
- Status
- UNKNOWN
- Phase
- N/A
Quality of Life (QoL) in Subjects With Acromegaly Under Lanreotide Autogel® Treatment.
- Status
- COMPLETED
- Phase
- N/A
Study to Determine the Maximum Tolerated Dose, Safety and Tolerability of a Single Dose of Lanreotide Prolonged Release Formulation (PRF) in Subjects With Acromegaly
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Acromegaly & Sleep Apnoea
- Status
- COMPLETED
- Phase
- N/A
Pasireotide in Patients With Acromegaly Inadequately Controlled With First Generation Somatostatin Analogues
- Status
- COMPLETED
- Phase
- PHASE3
Phase II Study of Subcutaneous Inj. Depot of Octreotide in Patients With Acromegaly and Neuroendocrine Tumours (NETs)
- Status
- COMPLETED
- Phase
- PHASE2
Late Effects of Radiosurgery on Acromegaly Study
- Status
- COMPLETED
- Phase
- NA
Clomiphene Citrate for Treatment of Acromegaly
- Status
- COMPLETED
- Phase
- PHASE2
Single Dose Pharmacology Study of DG3173 and Octreotide in Acromegalic Patients.
- Status
- COMPLETED
- Phase
- PHASE2
SAGIT for Classification of Patients With Acromegaly in Clinical Practice
- Status
- COMPLETED
- Phase
- N/A
The Effect of Subcutaneous Infusions of 3 Doses of DG3173 on Growth Hormone Levels in Untreated Acromegalics
- Status
- COMPLETED
- Phase
- PHASE2
Growth Hormone, IGF-1 and Medical Treatment in Acromegaly: Are There Effects on Gut Hormone Physiology and Postprandial Substrate Metabolism?
- Status
- COMPLETED
- Phase
- N/A
Assessment of Changes in Metabolic Activity in Liver & Skeletal Muscle in Patients Suffering From Acromegaly
- Status
- UNKNOWN
- Phase
- N/A
Phase II Study With ITF2984 in Acromegalic Patients
- Status
- COMPLETED
- Phase
- PHASE2
Pituitary Histopathology and Hyperprolactinaemia and Risk of Glucose Metabolic Disturbances in Acromegaly.
- Status
- UNKNOWN
- Phase
- N/A